Reports show a reduction in ankyrin-B expression in the atria of patients with documented AF, suggesting that ankyrin-B was required for the membrane targeting and function of Cav1.3 in atrial myocytes (Mesirca et al., 2021). This evidence concerns the gene ANK2 and atrial fibrillation.